QUEST &lt;QBIO> SIGNS PACT WITH ALZA &lt;AZA>

  Quest Biotechnology Inc said its Quest
  Blood Substitute Inc subsidiary executed an agreement with Alza
  Corp &lt;AZA> which will make Alza a preferred shareholder of its
  subsidiary.
      Quest said the agreement also offers Alza the right to
  acquire up to 25 pct of the unit's equity in exchange for the
  acquisition of patent rights to Alza technology in an area
  where Quest has an interest.
      Quest also said its signed a merger agreement with &lt;Hunt
  Research Corp> and its affiliate &lt;ICAS Corp>. Quest said it
  expects to complete the merger within the next several weeks.
  

